bottromycin: bottromycin is a complex of 5 compounds of which the main one is bottromycin A(2) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3081434 |
| SCHEMBL ID | 9753994 |
| MeSH ID | M0083224 |
| Synonym |
|---|
| bottromycic a2 acid, methyl ester |
| i 337b |
| cis-3-methyl-l-prolyl-l-valyl-n1-(carboxymethyl)-3-methylvalinimidoyl-3-methylvalyl-beta-methylphenylalanyl-3-(2-thiazolyl)-beta-alanine 6-methyl ester cyclic (3-1)-peptide stereoisomer |
| methyl 3-[[2-[[2-[(6-tert-butyl-13-methyl-2,8,11-trioxo-9-propan-2-yl-1,4,7,10-tetrazabicyclo[10.3.0]pentadec-4-en-5-yl)amino]-3,3-dimethylbutanoyl]amino]-3-phenylbutanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate |
| bottromycin |
| SCHEMBL9753994 |
| Q15634144 |
| BS-1032 |
| bottromycin a2; bottromycic a2 acid methyl ester; i-337b; ma 251c1 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.22) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (6.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (93.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||